Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2results about How to "Trend down" patented technology

A levitated optical mechanical system

ActiveCN116840968BHigh refractive indexImprove stabilityOptical cavityScattering loss
The application provides a suspended optical mechanical system, comprising a first substrate block, a suspended waveguide, a suspended support beam, a plurality of support tether groups, a suspended detection mass and an optical cavity, wherein the suspended waveguide comprises a linear main body part extending along an X direction and a plurality of connection parts arranged in sequence and at intervals along the X direction, and the support tether groups are connected to the section of the suspended waveguide with the connection parts, the stability of the connection of the support tether and the suspended waveguide is increased, the width of the suspended waveguide at the connection parts is enlarged, the optical mode can be well limited in the waveguide, and the influence of the support tether on the optical mode is minimized. The tapered part of the connection part ensures the singularity of the mode in the process of light field transmission and slows down the change trend of the width of the suspended waveguide, which is beneficial to reduce the scattering loss and further increase the quality factor. The connection part arranged on one side can ensure that the gap width between the suspended waveguide and the optical cavity is constant, thereby ensuring the optimal coupling efficiency.
Owner:ANYON TECHNOLOGIES PTE LTD

Amylin analogues

The present invention relates to amylin analogues and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogues have good physical and chemical stability, good solubility, and a long duration of action, and are well suited for use in the form of a liquid formulation.
Owner:ZEALAND PHARMA AS